Technical / White Paper
Fill-Finish Biologics

The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion, while the blockbuster Keytruda could be the top-selling drug with almost $25 billion in sales.